A CASE OF CHOROIDAL NEOVASCULAR MEMBRANE IN ENHANCED S-CONE SYNDROME TREATED WITH AFLIBERCEPT.

Retin Cases Brief RepOct 28, 2026
Case ReportOphthalmologyMedical Genetics

Maxwell J Gelkopf, Thomas G Sheidow, Verena R Juncal

✦ AI-curated · Sources linked

Case in brief

An 18-year-old male presented after six days of declining vision in his left eye. Testing showed foveomacular schisis in the right eye and active choroidal neovascularization in the left; further evaluation confirmed enhanced S-cone syndrome. Intravitreal aflibercept was followed by regression of the neovascularization and improved visual acuity.

What made this case unusual

The case describes active choroidal neovascularization in a patient with enhanced S-cone syndrome, an association reported in only a subset of patients with the disorder.

Diagnostic / clinical pearl

In enhanced S-cone syndrome, new visual decline may reflect choroidal neovascularization; assess for this alongside other retinal findings.

Source

PubMed · PMID 40986784

Published in Retin Cases Brief Rep. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Ophthalmology

Clinical ResearchVascular SurgeryOpen access

Revascularization of Asymptomatic Carotid Artery Stenosis: Cognitive Results of the CREST-2 Randomized Trials.

This prespecified cognitive-outcomes analysis of the multicentre, randomised CREST-2 trials assessed patients aged 35 years or older with at least 70% asymptomatic carotid stenosis.

JAMAOct 27, 2026Read summary
Clinical ResearchObstetrics & GynecologyOpen access

Intrauterine Mepivacaine Instillation vs Placebo for Pain During IUD Placement: A Randomized Clinical Trial.

This multicentre, double-blind, randomised, placebo-controlled trial tested intrauterine mepivacaine before IUD placement in nulliparous individuals aged 18 to 31 years at 11 Swedish clinics.

JAMAOct 27, 2026Read summary
Clinical ResearchOncology (Medical)

Zamtocabtagene autoleucel, a tandem CD20-CD19-directed CAR T-cell therapy, for second line treatment of large B-cell lymphoma in patients ineligible for transplantation (DALY 2-EU): primary analysis of an open-label, multicentre, randomised phase 2 study.

DALY 2-EU was an open-label, multicentre, randomised phase 2 trial comparing tandem CD20-CD19-directed zamtocabtagene autoleucel (zamto-cel) with R-GemOx in adults with second-line relapsed or refractory large B-cell…

Lancet OncolOct 27, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text
Create my personalized digestSee plans

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.